These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 1779452

  • 21. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A.
    Pfitzner SA, Dempfle CE, Matsuda M, Heene DL.
    Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756
    [Abstract] [Full Text] [Related]

  • 22. [Changes in coagulation parameters during the clinical courses of recipients of living-related partial liver transplantation].
    Okumura N, Matsuzawa A, Terasawa F, Sasaki Y, Nakagoshi R, Ishikawa S, Hashikura Y, Matsunami H, Kawasaki S, Makuuchi M.
    Rinsho Byori; 1995 Aug; 43(8):829-35. PubMed ID: 7474443
    [Abstract] [Full Text] [Related]

  • 23. [Intravascular coagulation in acute promyelocytic leukemia: analysis of coagulation and fibrinolysis parameters].
    Chuecas F, Loredo E, Muñoz B, Alfaro J, Grebe G, Lira P.
    Rev Med Chil; 1991 Sep; 119(9):984-9. PubMed ID: 1845106
    [Abstract] [Full Text] [Related]

  • 24. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S, Handa S, Abe S, Takahashi E, Kawai Y, Watanabe K, Yoshikawa T, Hori S, Ikeda Y.
    J Cardiol; 1993 Sep; 23(4):335-41. PubMed ID: 8064582
    [Abstract] [Full Text] [Related]

  • 25. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies.
    Elms MJ, Bunce IH, Bundesen PG, Rylatt DB, Webber AJ, Masci PP, Whitaker AN.
    Thromb Haemost; 1983 Aug 30; 50(2):591-4. PubMed ID: 6356456
    [Abstract] [Full Text] [Related]

  • 26. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
    Isogai N, Kuroso K, Fujimaki M, Yorifuji H, Fukutake K.
    Rinsho Byori; 1993 Dec 30; 41(12):1349-52. PubMed ID: 8295346
    [Abstract] [Full Text] [Related]

  • 27. [Clinical application of laboratory diagnosis: leukemia and DIC].
    Deguchi K, Zhao LJ, Shirakawa S.
    Rinsho Byori; 1991 Jul 30; 39(7):736-42. PubMed ID: 1833571
    [Abstract] [Full Text] [Related]

  • 28. [Differentiation between fibrin degradation products and fibrinogen degradation products by using newly developed ELISAs].
    Isogai N, Yamagishi T, Kaku M, Matsumoto K, Yamamoto Y, Kuroso K, Arai M, Yorifuji H, Fukutake K, Fujimaki M.
    Rinsho Byori; 1991 Jul 30; 39(7):753-7. PubMed ID: 1920869
    [Abstract] [Full Text] [Related]

  • 29. [Studies on the fragments of FDP in 3 patients with DIC associated with acute promyelocytic leukemia].
    Okumura N, Furuwatari C, Ishikawa S, Furihata K, Katsuyama T, Kanai M, Nakahata T, Saitoh H.
    Rinsho Byori; 1993 Jun 30; 41(6):719-25. PubMed ID: 8361040
    [Abstract] [Full Text] [Related]

  • 30. [Measurement of FDP-D-dimer in DIC and pre-DIC].
    Takagi M, Wada H, Tanigawa M, Iwasaki E, Deguchi A, Mori Y, Suzuki H, Ohkubo I, Endou T, Deguchi K.
    Rinsho Byori; 1990 Jul 30; 38(7):806-12. PubMed ID: 2205744
    [Abstract] [Full Text] [Related]

  • 31. High D-dimer levels: a possible index of risk of overt disseminated intravascular coagulation and/or digestive bleeding in advanced liver cirrhosis?
    Cioni G, Cristani A, Vignoli A, Ventura E.
    Recenti Prog Med; 1994 Apr 30; 85(4):230-4. PubMed ID: 8016448
    [Abstract] [Full Text] [Related]

  • 32. Activation of the fibrinolytic system in patients with fulminant liver failure.
    Pernambuco JR, Langley PG, Hughes RD, Izumi S, Williams R.
    Hepatology; 1993 Dec 30; 18(6):1350-6. PubMed ID: 8244260
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [A new advance in theory of blood coagulation and fibrinolysis and its practical application].
    Matsuno K, Araki K.
    Rinsho Byori; 1991 Feb 30; 39(2):179-84. PubMed ID: 1904112
    [Abstract] [Full Text] [Related]

  • 36. Incidence and clinical significance of elevated fibrin(ogen) degradation product and/or D-dimer levels in liver cirrhosis patients.
    Cioni G, Cristani A, Mussini C, Grandi S, Pentore R, Zeneroli ML, Tizzanini W, Zagni G, Ventura E.
    Ital J Gastroenterol; 1990 Apr 30; 22(2):70-4. PubMed ID: 2131934
    [Abstract] [Full Text] [Related]

  • 37. [A coagulation of fibrinolytic study in children with nephrotic syndrome: evaluation of hypercoagulability by measuring with plasmin- alpha 2 plasmin inhibitor complex and FDP D-dimer].
    Oikawa T, Muramatsu Y, Akashi S, Usui N.
    Nihon Jinzo Gakkai Shi; 1997 Mar 30; 39(2):144-9. PubMed ID: 9134831
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.